WHO Archives -

In the first of a three-part series, Ben Hargreaves looks at what the odds are of another pandemic

Preventing the next pandemic: Learning the lessons

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-learning-the-lessons/

Patients/ Views & Analysis/ Views and analysis

Studying inequities throughout the pandemic

Jessica Hagen COVID-19, vaccines, WHO, world health organization 0 Comment

Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH)

Studying inequities throughout the pandemic

https://pharmaphorum.com/patients/studying-inequities-throughout-the-pandemic/

R&D/ Views & Analysis/ Views and analysis

Can psychedelics provide breakthrough in mental health?

Ben Hargreaves DMT, LSD, psilocybin, psychedelics, WHO 0 Comment

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they

Can psychedelics provide breakthrough in mental health?

https://pharmaphorum.com/r-d/can-psychedelics-provide-breakthrough-in-mental-health/

Deep Dive/ Digital/ Views & Analysis/ Views and analysis

The rise, acceleration and acceptance of telehealth adoption

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Digital Health 2021, Digital Health 2021, Research Partnership, WHO, World Health Organisation 0 Comment

‘Healing at a distance’ is the literal meaning of telemedicine. According to the World Health Organization, it is

The rise, acceleration and acceptance of telehealth adoption

https://pharmaphorum.com/digital/acceleration-acceptance-telehealth-adoption/

Market Access/ News/ News

Two new drugs added to WHO list of COVID-19 therapies

Joy Persaud COVID-19, Eli Lilly, GlaxoSmithKline, market access, pharma, regulation, WHO 0 Comment

A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19.

Two new drugs added to WHO list of COVID-19 therapies

https://pharmaphorum.com/news/two-new-drugs-added-to-who-list-of-covid-19-therapies/

Market Access/ News/ News

J&J deal with COVAX grants humanitarian access to COVID shot

Phil Taylor coronavirus, COVAX, COVID-19 vaccine, Gavi, Johnson & Johnson, WHO 0 Comment

Johnson & Johnson has reached an agreement to make its one-dose COVID-19 vaccine available to an arm of

J&J deal with COVAX grants humanitarian access to COVID shot

https://pharmaphorum.com/news/jj-deal-with-covax-grants-humanitarian-access-to-covid-shot/

News/ News/ R&D

WHO plans pandemic prevention study of COVID’s origins

Dominic Tyer COVID-19, WHO 0 Comment

The World Health Organization has set up a new scientific group to study the origins of COVID-19 in

WHO plans pandemic prevention study of COVID’s origins

https://pharmaphorum.com/news/who-pandemic-prevention-study-covids-origins/

Market Access/ News/ News

Novavax files its COVID jab to WHO for emergency use listing

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, Novavax, Serum Institute of India, WHO 0 Comment

Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency

Novavax files its COVID jab to WHO for emergency use listing

https://pharmaphorum.com/news/novavax-files-its-covid-jab-to-who-for-emergency-use-listing/

Patients/ Views & Analysis/ Views and analysis

Build back better: US pharma and the future of healthcare

Amanda Barrell COVID-19, diversity and inclusion, health equity, WHO 0 Comment

America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable,

Build back better: US pharma and the future of healthcare

https://pharmaphorum.com/views-and-analysis/us-pharma-and-the-future-of-healthcare/

Trending

WHO

Login